People | October 27, 2022
Robert M. Davis is the new Chairman of Merck
Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021.
Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021.
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA
The company anticipates 2025 worldwide sales to be between $64.1 billion and $65.6 billion
With the addition of Karsanbhai, the Merck board will consist of 13 members
Sales reflect continued strong growth in oncology and vaccines
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and other autoimmune conditions
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The JUST 100 is the only ranking that recognizes companies doing right by all their stakeholders as defined by the American public.
Acquisition expands Merck’s growing hematology portfolio
Subscribe To Our Newsletter & Stay Updated
